Document Detail


Prostate gland edema after single-fraction high-dose rate brachytherapy before external beam radiation therapy.
MedLine Citation:
PMID:  20149758     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: High-dose rate brachytherapy (HDRB) is frequently used as a boost to external beam radiation therapy (EBRT) in prostate cancer patients. With the increasing use of small planning target volume margins in EBRT, prostatic edema induced by HDRB can be a contributing factor to geometric miss when HDRB is performed before or during EBRT. We assessed prostate gland volumetric change after single-fraction HDRB and its impact on definition of treatment volume for EBRT.
METHODS AND MATERIALS: Thirty-one consecutive patients with intermediate-risk prostate cancer treated with single-fraction HDRB (10 Gy) combined with hypofractionated EBRT were analyzed. A second CT scan was performed 7 days after HDRB, and images were coregistered with the planning CT scan that contained the original clinical target volume (CTV). The post-HDRB prostate CTV volume was compared with the original CTV by a single observer.
RESULTS: All patients presented volumetric variation. In most cases (68%), the prostate increased in volume, whereas it decreased in 32%. The mean prostatic volume was 42.2 cc before HDRB and 43.6 cc after HDRB, representing a mean volume difference of 3.4%, ranging from -14.2% to 23.8% (p=0.756). This difference is the result of mean changes of 0.6mm (-6.1 to 6.6) in the anterior-posterior, 0.5mm (-5.5 to 3.0) in the lateral, and 0.2mm (-5.0 to 5.0) in the superior-inferior axes.
CONCLUSIONS: Although a nonsignificant volumetric change occurs after single-fraction HDRB, individual variations on specific axis could lead to important uncertainties during EBRT.
Authors:
Fabio L Cury; Marie Duclos; Armen Aprikian; Horacio Patrocinio; Luis Souhami
Related Documents :
20367408 - Impact of prostate cancer multifocality on its biology and treatment.
19011298 - Testosterone and prostate safety.
11240828 - Effect of prostatic neuropeptides on migration of prostate cancer cell lines.
22113258 - Phenocopy breast cancer rates in israeli brca1 brca2 mutation carrier...
19318558 - Coordinates in the universe of node-negative breast cancer revisited.
15881278 - Propionibacterium acnes is the most common bacterium commensal in peripheral lung tissu...
Publication Detail:
Type:  Journal Article     Date:  2010-02-09
Journal Detail:
Title:  Brachytherapy     Volume:  9     ISSN:  1873-1449     ISO Abbreviation:  Brachytherapy     Publication Date:    2010 Jul-Sep
Date Detail:
Created Date:  2010-07-26     Completed Date:  2010-12-15     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101137600     Medline TA:  Brachytherapy     Country:  United States    
Other Details:
Languages:  eng     Pagination:  208-12     Citation Subset:  IM    
Copyright Information:
(c) 2010. Published by Elsevier Inc.
Affiliation:
Division of Radiation Oncology, Department of Oncology, McGill University Health Centre, Montreal, Quebec, Canada. fabio.cury@muhc.mcgill.ca
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Brachytherapy / adverse effects*
Dose Fractionation
Edema / etiology*
Humans
Male
Prostate / radiation effects*
Prostatic Neoplasms / complications,  radiotherapy*
Radiotherapy, Conformal
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clinical features of psychogenic nonepileptic seizures: A study of 64 cases in southwest China.
Next Document:  Investigation of geometric distortions on magnetic resonance and cone beam computed tomography image...